| Angel J Tamez, MD | |
|
222 E Ridge Rd Ste 106, Mcallen, TX 78503-1251 | |
| (956) 992-0404 | |
| (956) 992-0414 |
| Full Name | Angel J Tamez |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 26 Years |
| Location | 222 E Ridge Rd Ste 106, Mcallen, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215956834 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | N6058 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rio Grande Regional Hospital | Mcallen, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcallen Comprehensive Upper Extremity Center Pllc | 8123307576 | 3 |
News Archive
In a recently published study in the Journal of Biological Chemistry, Saint Louis University professor of pharmacological and physiological sciences Daniela Salvemini, Ph.D. describes two discoveries: a molecular pathway by which a painful chemotherapy side effect happens and a drug that may be able to stop it.
Men and women have long been promised a male version of the female contraceptive pill. But the first new male contraceptive to market may not be hormonal at all.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced a collaboration and license agreement with Panacor Bioscience Ltd. to develop and commercialize its Nephoxil(R) pharmaceutical product for the treatment of hyperphosphatemia in China.
Doctoral candidate Banchiamlack Dessalegn and her mentor, Barbara Landau, the Dick and Lydia Todd Professor in the Department of Cognitive Science at Johns Hopkins, tackled that question via a query of their own: Would children who are given verbal cues while viewing mirror image visual patterns remember them more accurately, and longer, than would children who were not given those cues?
Medivir AB, the research-based speciality pharmaceutical company focused on the development of high-value treatments for infectious diseases, notes that its development partner, Tibotec Pharmaceuticals, has announced the results of a Week-24 planned interim analysis of the Phase 2 response-guided PILLAR study for TMC435, Medivir's key pipeline asset, a hepatitis C protease inhibitor dosed once-daily.
› Verified 3 days ago
| Entity Name | Bhs Physicians Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598958431 PECOS PAC ID: 7315019593 Enrollment ID: O20080703000069 |
News Archive
In a recently published study in the Journal of Biological Chemistry, Saint Louis University professor of pharmacological and physiological sciences Daniela Salvemini, Ph.D. describes two discoveries: a molecular pathway by which a painful chemotherapy side effect happens and a drug that may be able to stop it.
Men and women have long been promised a male version of the female contraceptive pill. But the first new male contraceptive to market may not be hormonal at all.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced a collaboration and license agreement with Panacor Bioscience Ltd. to develop and commercialize its Nephoxil(R) pharmaceutical product for the treatment of hyperphosphatemia in China.
Doctoral candidate Banchiamlack Dessalegn and her mentor, Barbara Landau, the Dick and Lydia Todd Professor in the Department of Cognitive Science at Johns Hopkins, tackled that question via a query of their own: Would children who are given verbal cues while viewing mirror image visual patterns remember them more accurately, and longer, than would children who were not given those cues?
Medivir AB, the research-based speciality pharmaceutical company focused on the development of high-value treatments for infectious diseases, notes that its development partner, Tibotec Pharmaceuticals, has announced the results of a Week-24 planned interim analysis of the Phase 2 response-guided PILLAR study for TMC435, Medivir's key pipeline asset, a hepatitis C protease inhibitor dosed once-daily.
› Verified 3 days ago
| Entity Name | Rafael Rafols Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891071106 PECOS PAC ID: 7113193764 Enrollment ID: O20120103000130 |
News Archive
In a recently published study in the Journal of Biological Chemistry, Saint Louis University professor of pharmacological and physiological sciences Daniela Salvemini, Ph.D. describes two discoveries: a molecular pathway by which a painful chemotherapy side effect happens and a drug that may be able to stop it.
Men and women have long been promised a male version of the female contraceptive pill. But the first new male contraceptive to market may not be hormonal at all.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced a collaboration and license agreement with Panacor Bioscience Ltd. to develop and commercialize its Nephoxil(R) pharmaceutical product for the treatment of hyperphosphatemia in China.
Doctoral candidate Banchiamlack Dessalegn and her mentor, Barbara Landau, the Dick and Lydia Todd Professor in the Department of Cognitive Science at Johns Hopkins, tackled that question via a query of their own: Would children who are given verbal cues while viewing mirror image visual patterns remember them more accurately, and longer, than would children who were not given those cues?
Medivir AB, the research-based speciality pharmaceutical company focused on the development of high-value treatments for infectious diseases, notes that its development partner, Tibotec Pharmaceuticals, has announced the results of a Week-24 planned interim analysis of the Phase 2 response-guided PILLAR study for TMC435, Medivir's key pipeline asset, a hepatitis C protease inhibitor dosed once-daily.
› Verified 3 days ago
| Entity Name | Mcallen Comprehensive Upper Extremity Center Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154774644 PECOS PAC ID: 8123307576 Enrollment ID: O20161108001046 |
News Archive
In a recently published study in the Journal of Biological Chemistry, Saint Louis University professor of pharmacological and physiological sciences Daniela Salvemini, Ph.D. describes two discoveries: a molecular pathway by which a painful chemotherapy side effect happens and a drug that may be able to stop it.
Men and women have long been promised a male version of the female contraceptive pill. But the first new male contraceptive to market may not be hormonal at all.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced a collaboration and license agreement with Panacor Bioscience Ltd. to develop and commercialize its Nephoxil(R) pharmaceutical product for the treatment of hyperphosphatemia in China.
Doctoral candidate Banchiamlack Dessalegn and her mentor, Barbara Landau, the Dick and Lydia Todd Professor in the Department of Cognitive Science at Johns Hopkins, tackled that question via a query of their own: Would children who are given verbal cues while viewing mirror image visual patterns remember them more accurately, and longer, than would children who were not given those cues?
Medivir AB, the research-based speciality pharmaceutical company focused on the development of high-value treatments for infectious diseases, notes that its development partner, Tibotec Pharmaceuticals, has announced the results of a Week-24 planned interim analysis of the Phase 2 response-guided PILLAR study for TMC435, Medivir's key pipeline asset, a hepatitis C protease inhibitor dosed once-daily.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angel J Tamez, MD 222 E Ridge Rd Ste 106, Mcallen, TX 78503-1251 Ph: (956) 992-0404 | Angel J Tamez, MD 222 E Ridge Rd Ste 106, Mcallen, TX 78503-1251 Ph: (956) 992-0404 |
News Archive
In a recently published study in the Journal of Biological Chemistry, Saint Louis University professor of pharmacological and physiological sciences Daniela Salvemini, Ph.D. describes two discoveries: a molecular pathway by which a painful chemotherapy side effect happens and a drug that may be able to stop it.
Men and women have long been promised a male version of the female contraceptive pill. But the first new male contraceptive to market may not be hormonal at all.
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced a collaboration and license agreement with Panacor Bioscience Ltd. to develop and commercialize its Nephoxil(R) pharmaceutical product for the treatment of hyperphosphatemia in China.
Doctoral candidate Banchiamlack Dessalegn and her mentor, Barbara Landau, the Dick and Lydia Todd Professor in the Department of Cognitive Science at Johns Hopkins, tackled that question via a query of their own: Would children who are given verbal cues while viewing mirror image visual patterns remember them more accurately, and longer, than would children who were not given those cues?
Medivir AB, the research-based speciality pharmaceutical company focused on the development of high-value treatments for infectious diseases, notes that its development partner, Tibotec Pharmaceuticals, has announced the results of a Week-24 planned interim analysis of the Phase 2 response-guided PILLAR study for TMC435, Medivir's key pipeline asset, a hepatitis C protease inhibitor dosed once-daily.
› Verified 3 days ago
Dr. Alejandro Garza, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1100 E Dove Ave Ste 300, Mcallen, TX 78504 Phone: 956-362-8170 Fax: 956-362-8168 | |
Dr. Jorge Luis De La Garza, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 224 Lindberg Ave, Mcallen, TX 78501 Phone: 956-971-0066 Fax: 956-971-0072 | |
Mr. Jose Luis Almeda, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1100 E Dove Ave Ste 201, Mcallen, TX 78504 Phone: 569-362-5433 Fax: 569-362-2420 | |
Dr. Diego R Camacho, MD Surgery Medicare: May Accept Medicare Assignments Practice Location: 416 Lindberg Ave, Mcallen, TX 78501 Phone: 956-630-4161 Fax: 956-664-1398 | |
Fredricka M Borland, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 110 E Savannah Ave, Bldg A, Mcallen, TX 78503 Phone: 956-631-8155 Fax: 956-631-8187 | |
Dr. Roy Dewayne Edwards, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1100 E Dove Ave Ste 300, Mcallen, TX 78504 Phone: 956-362-8170 Fax: 956-362-8168 |